CA Patent

CA2253282A1 — 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs

Assigned to Hoechst AG · Expires 1997-11-06 · 29y expired

What this patent protects

Described are 3-alkoxypyridine-2-carboxylic acid amide esters of formula (I), wherein R1, R2 and R3 are hydrogen, R4 is a (C1-C6) alkyl, A is a -CH2 group in which one hydrogen can be replaced by a methyl group, and B is -CO2G, where G is the radical of a GOH alcohol, including t…

USPTO Abstract

Described are 3-alkoxypyridine-2-carboxylic acid amide esters of formula (I), wherein R1, R2 and R3 are hydrogen, R4 is a (C1-C6) alkyl, A is a -CH2 group in which one hydrogen can be replaced by a methyl group, and B is -CO2G, where G is the radical of a GOH alcohol, including the physiologically effective salts; their preparation, their use in inhibiting collagen biosynthesis, and their use as drugs for treating fibrotic diseases.

Drugs covered by this patent

Patent Metadata

Patent number
CA2253282A1
Jurisdiction
CA
Classification
Expires
1997-11-06
Drug substance claim
No
Drug product claim
No
Assignee
Hoechst AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.